New Jersey Department of Health Issues Rule Waiver for Opioid Treatment Programs

On February 24, 2025, the New Jersey Department of Health (NJDOH) announced the issuance of a rule waiver in order to align State rules with federal guidelines applicable to opioid treatment programs (OTPs). Therefore, in lieu of the waived requirements under New Jersey’s rules, OTPs must follow the federal rules. In the announcement, NJDOH stated the rule waiver will (i) increase access to opioid treatment services, (ii) reduce regulatory requirements on providers while maintaining the safe provision of services, and (iii) ensure medications for opioid use disorder (MOUD) are provided in accordance with best practices and regulatory standards.

Click Here to read the entire April 2024 Healthcare Law Update now!